Effect of systemic steroid treatment on serum leptin levels in patients with COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005
Oral corticosteroid treatment reduces serum chitotriosidase activity in patients with COPD Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010
Monitoring free serum IgE in severe asthma patients treated with omalizumab Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011
Monitoring free serum IgE in asthma patients treated with omalizumab Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010
Serum level of soluble interleukin-2 receptors (sIL-2R) during acute asthma exacerbation, and its relation to severity and response to bronchodilator therapy Source: Eur Respir J 2002; 20: Suppl. 38, 141s Year: 2002
Effect of corticosteroid therapy upon serum magnesium level in chronic asthmatic children Source: Annual Congress 2010 - Paediatric asthma, rhinitis and management Year: 2010
Serum YKL-40 modulation in severe asthma patients treated with Mepolizumab Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020
Interleukin-2 and C-reactive protein in assessing the effectiveness of pulmonary sarcoidosis treatment Source: International Congress 2017 – The many faces of sarcoidosis Year: 2017
One year monitoring of children with bronchial asthma and other allergic diseases treated with inhaled corticosteroids vs cromoglycates with serum ECP (S-ECP), FEV1, total IgE and blood eosinophil count - the influence of different therapy Source: Eur Respir J 2002; 20: Suppl. 38, 432s Year: 2002
The effects of hormone replacement therapy on airway function,skin tests to allergens and serum ECP levels in postmenopausal women Source: Eur Respir J 2002; 20: Suppl. 38, 425s Year: 2002
Serum Amphiregulin expression in severe asthma patients treated with anti-IL-5 therapy Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020
Indication for antibiotic therapy in AECB: anthonisen‘s criteria versus procalcitonin Source: Eur Respir J 2004; 24: Suppl. 48, 50s Year: 2004
Serum leptin levels in asthmatic children treated with inhaled corticosteroid Source: Eur Respir J 2004; 24: Suppl. 48, 580s Year: 2004
The assesment of serum TNFα levels in COPD acute exacerbation and the effects of inhaler steroids on clinical and inflammatory determinants Source: Eur Respir J 2002; 20: Suppl. 38, 312s Year: 2002
Plasma biomarkers and response to therapy at exacerbation of COPD Source: Eur Respir J 2007; 30: Suppl. 51, 39s Year: 2007
Procalcitonin in respiratory disease: use as a biomarker for diagnosis and guiding antibiotic therapy Source: Breathe, 15 (4) 296; 10.1183/20734735.0258-2019 Year: 2019
Free serum IgE suppression with omalizumab and clinical outcomes in asthma Source: International Congress 2019 – Clinical studies of asthma treatments Year: 2019
The effect of montelukast and triamcinolon on clinical parameters and serum levels of ECP, sIL-2R and IL-4 in children with moderate asthma Source: Eur Respir J 2001; 18: Suppl. 33, 123s Year: 2001
Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis Source: Eur Respir J 2014; 44: 789-791 Year: 2014
Influence of a combination therapy versus steroid monotherapy on FeNO Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009